New Alzheimer's Drugs Could Transform Treatment for Millions

A new generation of Alzheimer's drugs is showing unprecedented promise in clinical trials, with researchers saying the treatments could transform outcomes for the estimated 55 million people worldwide living with dementia. Unlike previous approaches that merely managed symptoms, these drugs target the underlying disease mechanisms to slow or halt progression. The breakthrough comes as brain aging research accelerates across multiple fronts, raising hopes for an era of genuine cognitive preservation.